Elanco Animal Health is making progress on debt repayment, new product approvals, and launches, despite a 20.5% stock decline since August 2024. The stock drop is mainly due to safety risks with the ...
4 analysts have shared their evaluations of Elanco Animal Health (NYSE:ELAN) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed ...
Disclosed in the latest SEC filing, a significant insider purchase on December 15, involves Robert M VanHimbergen, EVP and CFO at Elanco Animal Health (NYSE:ELAN). What Happened: VanHimbergen ...
In a recent SEC filing, it was revealed that Jeffrey N Simmons, President at Elanco Animal Health (NYSE:ELAN), made a noteworthy insider purchase on December 15,. What Happened: Simmons made a ...
In this settled action, In the Matter of Elanco Animal Health, Inc., Elanco, a manufacturer and seller of animal health products, such as flea and tick medications, was charged with “failure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results